Defining a mutational signature for endometrial cancer screening and early detection.

Affiliation

Cancer Epidemiology Research Programme, IDIBELL, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain. Electronic address: [Email]

Abstract

The current availability of genomic information represents an opportunity to develop new strategies for early detection of cancer. New molecular tests for endometrial cancer may improve performance and failure rates of histological aspirate-based diagnosis, and provide promising perspectives for a potential screening scenario. However, the selection of relevant biomarkers to develop efficient strategies can be a challenge.

Keywords

Algorithm,Biomarkers,Early detection,Endometrial cancer,Genomics,Screening,

OUR Recent Articles